JAKAVI
As listed in the register: JAKAVI 20 mg, comprimé
26,4 mg · comprimé
- Prescription only
- Active substance
- Phosphate De Ruxolitinib
- Made by
- NOVARTIS EUROPHARM (IRLANDE)
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | NOVARTIS EUROPHARM (IRLANDE) |
|---|---|
| Active substance | Phosphate De Ruxolitinib |
| Strength | 26,4 mg |
| Form | comprimé |
| Route | orale |
| Dispensing (as stated by the register) | médicament nécessitant une surveillance particulière pendant le traitement · prescription réservée aux spécialistes et services HEMATOLOGIE · prescription hospitalière · liste I · prescription réservée aux médecins compétents en maladie du sang |
| Marketed | Yes, according to the register |
| Authorisation procedure | Procédure centralisée |
| EU number | EU/1/12/773 |
| Name in the register | JAKAVI 20 mg, comprimé |
| Packs | plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 56 comprimé(s) |
| CIS | 66180136 |
| CIP13 | 3400927326295 |
Source: Base de données publique des médicaments · 2026-09-30 · not reviewed by a clinician
Source : Base de données publique des médicaments (ANSM / Ministère de la Santé), sous Licence Ouverte. Reuse terms: Licence Ouverte / Open Licence (Etalab).
Other strengths and forms
4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.